Should You Buy This Blue Chip Dividend Stock?

04:15pm, Saturday, 12'th Mar 2022 The Motley Fool
Bristol-Myers Squibb has significantly outperformed the broader market year to date.

Should You Buy This Blue Chip Dividend Stock?

04:15pm, Saturday, 12'th Mar 2022 The Motley Fool
Bristol-Myers Squibb has significantly outperformed the broader market year to date.

Should You Buy This Blue Chip Dividend Stock?

11:15am, Saturday, 12'th Mar 2022
Bristol-Myers Squibb has significantly outperformed the broader market year to date.
Bristol Myers, Eli Lilly and two others prove you can still make money investing in medical stocks — if you know where to look.

Pfizer''s Newest Way To Rival Bristol Myers Squibb Might Surprise You

05:13pm, Friday, 11'th Mar 2022 Investor''s Business Daily
Pfizer stock rose near its 50-day line Friday after the drug giant wrapped its $6.7 billion takeover of biotech Arena Pharmaceuticals.

3 Unstoppable Growth Stocks to Buy in 2022 and Beyond

04:45pm, Thursday, 10'th Mar 2022 The Motley Fool
There is no shortage of opportunities for these businesses to get much bigger in the years ahead.

2 Top Dividend Stocks You Can Buy for Less Than $100 Per Share

03:45pm, Thursday, 10'th Mar 2022 The Motley Fool
Some cheap stocks are worth investing in.
Saturna Capital, an investment management firm, published its “Amana Funds” fourth-quarter 2021 investor letter – a copy of which can be downloaded here.
There is no shortage of opportunities for these businesses to get much bigger in the years ahead.
Some cheap stocks are worth investing in.
Which pharmaceutical companies can rocket your portfolio right now? Let's take a look.
These ETFs can balance stability and long-term growth.

What Stocks Does 'The Big Short' Investor Michael Burry Own?

03:35pm, Wednesday, 09'th Mar 2022 Benzinga
Michael Burry is the founder and former hedge fund manager of now-defunct Scion Capital, most famously known for his massively profitable contrarian investment in the events leading up to the collapse

7 Biotech Stocks With Key Catalysts in March

06:24am, Wednesday, 09'th Mar 2022
These seven stocks have some key catalysts lined up for March with the potential to move their price actions in big ways. The post 7 Biotech Stocks With Key Catalysts in March appeared first on Invest
Of the $17 billion in annual sales that will be lost to copycat drugs this year, a Bristol-Myers Squibb Co. ( BMY , Financial) cancer medication is in line to take the biggest hit.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE